BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34861797)

  • 1. Modelling of Hepatitis E virus RNA-dependent RNA polymerase genotype 3 from a chronic patient and
    Cancela F; Rendon-Marin S; Quintero-Gil C; Houston DR; Gumbis G; Panzera Y; PĂ©rez R; Arbiza J; Mirazo S
    J Biomol Struct Dyn; 2023 Feb; 41(2):705-721. PubMed ID: 34861797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribavirin Treatment Failure-Associated Mutation, Y1320H, in the RNA-Dependent RNA Polymerase of Genotype 3 Hepatitis E Virus (HEV) Enhances Virus Replication in a Rabbit HEV Infection Model.
    Wang B; Mahsoub HM; Li W; Heffron CL; Tian D; Hassebroek AM; LeRoith T; Meng XJ
    mBio; 2023 Apr; 14(2):e0337222. PubMed ID: 36809085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenic Effects of Ribavirin on Hepatitis E Virus-Viral Extinction versus Selection of Fitness-Enhancing Mutations.
    Todt D; Walter S; Brown RJ; Steinmann E
    Viruses; 2016 Oct; 8(10):. PubMed ID: 27754363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zinc Salts Block Hepatitis E Virus Replication by Inhibiting the Activity of Viral RNA-Dependent RNA Polymerase.
    Kaushik N; Subramani C; Anang S; Muthumohan R; Shalimar ; Nayak B; Ranjith-Kumar CT; Surjit M
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28814517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipients.
    Debing Y; Gisa A; Dallmeier K; Pischke S; Bremer B; Manns M; Wedemeyer H; Suneetha PV; Neyts J
    Gastroenterology; 2014 Nov; 147(5):1008-11.e7; quiz e15-6. PubMed ID: 25181691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repurposing of artesunate, an antimalarial drug, as a potential inhibitor of hepatitis E virus.
    Bhise N; Agarwal M; Thakur N; Akshay PS; Cherian S; Lole K
    Arch Virol; 2023 Apr; 168(5):147. PubMed ID: 37115342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High dose sofosbuvir and sofosbuvir-plus-ribavirin therapy inhibit Hepatitis E Virus (HEV) replication in a rabbit model for acute HEV infection.
    Liang Z; Shu J; He Q; Zhang F; Dai L; Wang L; Lu F; Wang L
    Antiviral Res; 2022 Mar; 199():105274. PubMed ID: 35247472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis E virus: Epidemiology, diagnosis, clinical manifestations, and treatment.
    Aslan AT; Balaban HY
    World J Gastroenterol; 2020 Oct; 26(37):5543-5560. PubMed ID: 33071523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribavirin for Hepatitis E Virus Infection After Organ Transplantation: A Large European Retrospective Multicenter Study.
    Kamar N; Abravanel F; Behrendt P; Hofmann J; Pageaux GP; Barbet C; Moal V; Couzi L; Horvatits T; De Man RA; Cassuto E; Elsharkawy AM; Riezebos-Brilman A; Scemla A; Hillaire S; Donnelly MC; Radenne S; Sayegh J; Garrouste C; Dumortier J; Glowaki F; Matignon M; Coilly A; Figueres L; Mousson C; Minello A; Dharancy S; Rerolle JP; Lebray P; Etienne I; Perrin P; Choi M; Marion O; Izopet J;
    Clin Infect Dis; 2020 Aug; 71(5):1204-1211. PubMed ID: 31793638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive Regulation of Hepatitis E Virus Replication by MicroRNA-122.
    Haldipur B; Bhukya PL; Arankalle V; Lole K
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29540601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of active hepatitis E virus infection and efficacy of ribavirin treatment in renal allograft recipients.
    Friebus-Kardash J; Eisenberger U; Ackermann J; Kribben A; Witzke O; Wenzel J; Rohn H; Fiedler M
    Transpl Infect Dis; 2019 Jun; 21(3):e13088. PubMed ID: 30929308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral candidates against the hepatitis E virus (HEV) and their combinations inhibit HEV growth in in vitro.
    Nishiyama T; Kobayashi T; Jirintai S; Nagashima S; Primadharsini PP; Nishizawa T; Okamoto H
    Antiviral Res; 2019 Oct; 170():104570. PubMed ID: 31362004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin.
    Lhomme S; DebRoy S; Kamar N; Abravanel F; Metsu D; Marion O; Dimeglio C; Cotler SJ; Izopet J; Dahari H
    Viruses; 2019 Jul; 11(7):. PubMed ID: 31323954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome.
    Todt D; Gisa A; Radonic A; Nitsche A; Behrendt P; Suneetha PV; Pischke S; Bremer B; Brown RJ; Manns MP; Cornberg M; Bock CT; Steinmann E; Wedemeyer H
    Gut; 2016 Oct; 65(10):1733-43. PubMed ID: 27222534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis E virus treatment and ribavirin therapy: viral mechanisms of nonresponse.
    Todt D; Meister TL; Steinmann E
    Curr Opin Virol; 2018 Oct; 32():80-87. PubMed ID: 30384328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hepatitis E virus.
    Dalton HR; Kamar N
    Curr Opin Infect Dis; 2016 Dec; 29(6):639-644. PubMed ID: 27607911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribavirin therapy for hepatitis E virus-induced acute on chronic liver failure: a preliminary report.
    Goyal R; Kumar A; Panda SK; Paul SB; Acharya SK
    Antivir Ther; 2012; 17(6):1091-6. PubMed ID: 22910532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determining the therapeutic range for ribavirin in transplant recipients with chronic hepatitis E virus infection.
    Mulder MB; de Man RA; Kamar N; Durmaz G; de Bruijne J; Vanwolleghem T; Izopet J; Gandia P; van der Eijk AA; van Gelder T; Hesselink DA; de Winter BCM
    J Viral Hepat; 2021 Feb; 28(2):431-435. PubMed ID: 33135238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of hepatitis E virus infection of genotype 1 and 3 in mice with humanised liver.
    Sayed IM; Verhoye L; Cocquerel L; Abravanel F; Foquet L; Montpellier C; Debing Y; Farhoudi A; Wychowski C; Dubuisson J; Leroux-Roels G; Neyts J; Izopet J; Michiels T; Meuleman P
    Gut; 2017 May; 66(5):920-929. PubMed ID: 27006186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ribavirin for chronic hepatitis E virus infection in transplant recipients.
    Kamar N; Izopet J; Tripon S; Bismuth M; Hillaire S; Dumortier J; Radenne S; Coilly A; Garrigue V; D'Alteroche L; Buchler M; Couzi L; Lebray P; Dharancy S; Minello A; Hourmant M; Roque-Afonso AM; Abravanel F; Pol S; Rostaing L; Mallet V
    N Engl J Med; 2014 Mar; 370(12):1111-20. PubMed ID: 24645943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.